Nordion enters into agreement to divest targeted therapies business to BTG May 29, 2013 CenterWatch Staff
AstraZeneca to acquire Omthera, NDA-ready novel dyslipidemia treatment May 29, 2013 CenterWatch Staff
ThromboGenics, Eleven to develop novel therapeutic for ophthalmic disease May 29, 2013 CenterWatch Staff
BARDA awards Cempra $58M contract to develop antibiotic for pediatric use May 29, 2013 CenterWatch Staff
Ophthotech raises $175M for phase III Fovista anti-PDGF combo therapy in wet AMD May 29, 2013 CenterWatch Staff